SR

Srinivasa Raghavan Mathurakavi Ayyangar

Active Director Managing Director DIN 00090266
DIN 00090266 First appointment Mar 1992 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Mar 1992
Shareholding value •••• Premium profile

About Srinivasa Raghavan Mathurakavi Ayyangar

Data last updated:

Srinivasa Raghavan Mathurakavi Ayyangar has 34 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Emmessar Biotech And Nutrition Ltd and Twilight Litaka Pharma Limited. Formerly with 4 companies, such as Erudite Capital Counsel Private Limited and Erudite Capital Creations Private Limited. Engaged in Technology, General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹24.55 Cr; the largest is Emmessar Technologies Private Limited at ₹21.93 Cr (FY 2025).

DIN 00090266
Primary Designation Managing Director
First Appointment 17 Mar 1992
Oldest Company Age 52 yrs
Largest company Emmessar Technologies Private Limited · ₹21.93 Cr (FY 2025)
Combined revenue ₹24.55 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20071984₹21.93 Cr (FY 2025)Active
Emmessar Biotech And Nutrition Ltd L24110MH1992PLC065942
Managing Director17 Mar 19921992₹2.62 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jul 20002000–Strike Off
Director08 Dec 19941990₹2.6 Lakh (FY 2017)Strike Off
Director29 Sep 20061988₹1.86 Cr (FY 2025)Active
Twilight Litaka Pharma Limited L24231MH1974PTC017139
Director31 Dec 20051974₹31.51 Cr (FY 2014)Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emmessar Biotech And Nutrition Ltd
Twilight Litaka Pharma Limited
Emmessar Technologies Private Limited
Erudite Capital Counsel Private Limited
Premium access

Shareholding and investment profile for Srinivasa Raghavan Mathurakavi Ayyangar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Raghavan Mathurakavi Ayyangar

Srinivasa Raghavan Mathurakavi Ayyangar has 34 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Emmessar Biotech And Nutrition Ltd and Twilight Litaka Pharma Limited. Formerly with 4 companies, such as Erudite Capital Counsel Private Limited and Erudite Capital Creations Private Limited. Engaged in Technology, General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹24.55 Cr; the largest is Emmessar Technologies Private Limited at ₹21.93 Cr (FY 2025).

Srinivasa Raghavan Mathurakavi Ayyangar is associated with 2 companies as Managing Director and Director, including Emmessar Technologies Private Limited (₹21.93 Cr), Emmessar Biotech And Nutrition Ltd (₹2.62 Cr).

Srinivasa Raghavan Mathurakavi Ayyangar has expertise in Technology, General Business.

Srinivasa Raghavan Mathurakavi Ayyangar has 34 years in corporate governance.

By reported revenue, the largest current company of Srinivasa Raghavan Mathurakavi Ayyangar is Emmessar Technologies Private Limited, with revenue of ₹21.93 Cr (FY 2025).

The 2 current companies of Srinivasa Raghavan Mathurakavi Ayyangar that report revenue have a combined latest revenue of ₹24.55 Cr.

Srinivasa Raghavan Mathurakavi Ayyangar currently holds positions at 2 companies: Emmessar Technologies Private Limited (₹21.93 Cr), Emmessar Biotech And Nutrition Ltd (₹2.62 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available